337 related articles for article (PubMed ID: 36159818)
1. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
Front Immunol; 2022; 13():977338. PubMed ID: 36159818
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a Novel Prognostic Prediction Model for Gastric Cancer Based on Necroptosis-Related Genes.
Zhu ZZ; Zhang G; Liu J
Pathol Oncol Res; 2022; 28():1610641. PubMed ID: 36185996
[No Abstract] [Full Text] [Related]
3. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
Front Immunol; 2022; 13():968165. PubMed ID: 36389725
[TBL] [Abstract][Full Text] [Related]
4. Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic signature universal applicable for gastric cancer-A large sample and multicenter retrospective analysis.
Huo J; Xie W; Fan X; Sun P
Comput Biol Med; 2022 Oct; 149():106037. PubMed ID: 36044785
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic and therapeutic target biomarker based on necroptosis-related gene signature and immune microenvironment infiltration in gastric cancer.
Xin D; Man Y; Yang Y; Wang F
Front Genet; 2022; 13():953997. PubMed ID: 36092932
[No Abstract] [Full Text] [Related]
6. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
[TBL] [Abstract][Full Text] [Related]
8. Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function.
Wang SY; Wang YX; Shen A; Yang XQ; Liang CC; Huang RJ; Jian R; An N; Xiao YL; Wang LS; Zhao Y; Lin C; Wang CP; Yuan ZP; Yuan SQ
Eur J Med Res; 2024 Mar; 29(1):180. PubMed ID: 38494472
[TBL] [Abstract][Full Text] [Related]
9. Identification of N7-methylguanosine related subtypes and construction of prognostic model in gastric cancer.
Li X; Dong H; Chen L; Wang Y; Hao Z; Zhang Y; Jiao Y; Zhao Z; Peng X; Zhan X
Front Immunol; 2022; 13():984149. PubMed ID: 36300121
[TBL] [Abstract][Full Text] [Related]
10. AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer.
Zeng Y; Zhang X; Li F; Wang Y; Wei M
J Clin Lab Anal; 2022 Jun; 36(6):e24437. PubMed ID: 35478418
[TBL] [Abstract][Full Text] [Related]
11. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
Hu B; Meng Y; Qu C; Wang BY; Xiu DR
Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of 1804 samples of six centers to construct and validate a robust immune-related prognostic signature associated with stromal cell abundance in tumor microenvironment for gastric cancer.
Huo J; Guan G; Cai J; Wu L
World J Surg Oncol; 2022 Jan; 20(1):4. PubMed ID: 34983559
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden.
Ma W; Li W; Xu L; Liu L; Xia Y; Yang L; Da M
Pathol Oncol Res; 2021; 27():1609852. PubMed ID: 34566519
[No Abstract] [Full Text] [Related]
14. Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer.
Chen F; Yang J; Fang M; Wu Y; Su D; Sheng Y
J Clin Lab Anal; 2022 Apr; 36(4):e24302. PubMed ID: 35229919
[TBL] [Abstract][Full Text] [Related]
15. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer.
Huo J; Wu L; Zang Y
J Immunol Res; 2021; 2021():5554342. PubMed ID: 34007851
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel MSI-related ceRNA network for predicting the prognosis and immunotherapy response of gastric cancer.
Zhang L; Cao L; Liu J; Duan L; Zhou W; Li T; Guan L; Wu X; Zhang H
Aging (Albany NY); 2023 Jun; 15(11):5164-5189. PubMed ID: 37310469
[TBL] [Abstract][Full Text] [Related]
19. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
[No Abstract] [Full Text] [Related]
20. Development of a CD8+ T cell associated signature for predicting the prognosis and immunological characteristics of gastric cancer by integrating single-cell and bulk RNA-sequencing.
Li J; Han T; Wang X; Wang Y; Yang R; Yang Q
Sci Rep; 2024 Feb; 14(1):4524. PubMed ID: 38402299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]